Arash Moavenian

Impli is a pioneering biotechnology company dedicated to revolutionizing accessibility and efficacy in the world of in vitro fertilization (IVF). Our breakthrough innovation, a biosensing platform, a novel combination of electronics and subdermal biosensors, allows for the continuous monitoring of hormones crucial for egg retrieval, embryo transfer, and pregnancy development. Leveraging NFC technology, the device communicates seamlessly with modern smartphones, providing instant readings of three vital hormone levels. This capability eliminates the need for frequent blood draws, offering a convenient and accurate approach to enhancing IVF outcomes. Founded in April 2019, Impli was conceived with a mission to improve lives through cutting-edge implantable technology. Our inaugural product, ImpliCaspian, set the standard by enabling users to store and access medical information effortlessly via a smartphone app. Since then, our vision has evolved, focusing on the future of biosensors and the development of innovative products that provide real-time, hassle-free access to personal health data at the touch of a phone. The promise of our technology heralds a transformative era for IVF, with the potential to make it more accessible, reduce the number of required cycles, and significantly increase successful pregnancy rates. Our advancements have garnered recognition, including a feature in the Octopus Ventures Future of Fertility Report. At Impli, we are committed to shaping a healthier and safer world through the power of biotechnology one IVF journey at a time.

A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered

Bridgefy is software that makes any mobile app work without the Internet. Integrate the Bridgefy SDK today and change the world. 10 million users and counting.

Redefining care at home.

London medical design start up | Health and well being | Design and technology | Bowel disease and ostomy awareness |

Osteoarthritis causes chronic pain for 33% of the population and is treated with joint replacement. 1.3M knee replacements are performed globally every year - 450,000 of them are in young patients with high risk of failure and revision surgery. These patients experience poorer outcomes so surgeons are reluctant to treat them. OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Our implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. Our vision is to keep patients active, pain-free and enjoying added years of improved quality of life.

STAXY’s mission is to create a sustainable future for fan travel by working with sports clubs to track and reduce carbon emissions. Our technology enables us to accurately collect data on how all fans travel to fixtures, without requiring any input from fans themselves. We accurately track carbon emissions, fan travel patterns (in terms of cost, time, mode, and locations) and other key metrics to understand fan behaviour, preferences and sensitivities. Our data collection and analysis then serve as a foundation for crafting informed sustainability strategies, complying with regulations, and bolstering marketing efforts to enhance fan engagement. Furthermore, we support clubs and organisations to tangibly reduce emissions via our mobile platform (that can be integrated into existing apps). It enables fans to access low-cost and sustainable travel solutions such as carpooling, trains, E-mobility solutions and coach services.

Calla Lily Clinical Care is a British medical device startup developing Callavid®: a leak-free, convenient and dosage-confident delivery platform for vaginally-delivered drugs. We are initially focused on delivering progesterone for miscarriage prevention and IVF, where there is an unmet need for a patient-friendlier means of drug administration during an already stressful fertility journey. Progesterone prescriptions have significantly increased following the Nov 2021 update to internationally-renowned NICE’s guidance on miscarriages. Callavid® can also deliver menopausal treatments, targeted cancer treatments, and live biotherapeutics (LBPs) cutting antibiotic usage and reducing the spread of antimicrobial resistance (AMR). For pharmaceutical partners, Callavid® offers a differentiated drug delivery modality for pipeline drugs, and a means of extending the lifecycle of established assets including off-patent therapeutics. Our patented technology has received FDA clearance and was named one of TIME magazine’s Best Inventions of the Year.

Biolumen is a weight-loss and gut health company, on a mission to reverse the negative impact of the Western diet; like obesity, type 2 diabetes and autoimmune disorders. Biolumens product, Monch Monch, is a highly functional cellulose matrix which entraps calories in the stomach.

Collective cover by Laka We exist to rewrite the rules of insurance so it’s something people stand with, not against. That’s why we’re building a collective that gets stronger as it grows, covering each other as we fight against the broken and archaic in the pursuit of better. For press and media inquiries, please contact: press@laka.co

The Cheeky Panda wants you to know Bamboo is Awesome!! Bamboo is the worlds fastest growing plant and a big solution to a world with stretched resources. We have been a certified B Corp since 2019 and our products are 100% FSC certified and cruelty free. We also invest back into protecting the rain forests and are carbon neutral. The Cheeky Panda produces a range of products from various sizes of traditional toilet paper, facial tissues, kitchen towel, wipes and nappies. The products are available in over 25 countries and available online, through distributors and traditional retailers.

Thermulon’s process foregoes the current conditions that make aerogels difficult to manufacture. The result is rapid production of the world’s most insulating material.Our aerogels come in powders and granules. This versatility unlocks a variety of applications in insulating batts, blankets, panels and other products. Our partners are radical innovators in construction and EV battery technology whose products benefit from aerogels’ super-insulating properties, good fire performance and low density. Thermulon-based products can reach thermal conductivity of λ~20mW/mK: equivalent to plastics-based products. Unlike petroleum-derived insulation, silica-based aerogels have an inorganic material backbone and can achieve a fire-rating suitable for use in high-risk settings (limited combustibility).

Impli is a pioneering biotechnology company dedicated to revolutionizing accessibility and efficacy in the world of in vitro fertilization (IVF). Our breakthrough innovation, a biosensing platform, a novel combination of electronics and subdermal biosensors, allows for the continuous monitoring of hormones crucial for egg retrieval, embryo transfer, and pregnancy development. Leveraging NFC technology, the device communicates seamlessly with modern smartphones, providing instant readings of three vital hormone levels. This capability eliminates the need for frequent blood draws, offering a convenient and accurate approach to enhancing IVF outcomes. Founded in April 2019, Impli was conceived with a mission to improve lives through cutting-edge implantable technology. Our inaugural product, ImpliCaspian, set the standard by enabling users to store and access medical information effortlessly via a smartphone app. Since then, our vision has evolved, focusing on the future of biosensors and the development of innovative products that provide real-time, hassle-free access to personal health data at the touch of a phone. The promise of our technology heralds a transformative era for IVF, with the potential to make it more accessible, reduce the number of required cycles, and significantly increase successful pregnancy rates. Our advancements have garnered recognition, including a feature in the Octopus Ventures Future of Fertility Report. At Impli, we are committed to shaping a healthier and safer world through the power of biotechnology one IVF journey at a time.

A network for entrepreneurs building in stealth. Submit your information here so investors can find you: harmonic.ai/get-discovered

Bridgefy is software that makes any mobile app work without the Internet. Integrate the Bridgefy SDK today and change the world. 10 million users and counting.

Redefining care at home.

Plug and Play is a global innovation platform founded in Silicon Valley in 2006. We connect the people and organizations that drive technology forward, and turn those connections into real business outcomes. We run accelerator programs, facilitate corporate-startup pilots, invest in early-stage companies, and help governments and institutions build innovation ecosystems. Our network includes corporations, startups, investors, universities, and mentors across more than 20 industries and 60 locations worldwide. Since inception, weve accelerated thousands of startups and invested in over 2,500 companies. Our portfolio includes PayPal, Dropbox, LendingClub, Honey, and N26. Industries we work in: Advanced Manufacturing · Aerospace & Defense · Agtech · Animal Health · Brand & Retail · Crypto & Digital Assets · Deeptech · Energy · Enterprise & AI · Fintech · Food & Beverage · Health · Insurtech · Lifetech · Maritime · Media & Advertising · Medtech · Mobility & Physical AI · New Materials & Packaging · Real Estate & Construction · Semiconductors · Smart Cities · Sportstech · Supply Chain · Sustainability · Travel & Hospitality Where we operate: Americas: Silicon Valley · New York · Los Angeles · Washington D.C. · Detroit · Seattle · São Paulo · Alberta Europe: London · Munich · Stuttgart · Paris · Amsterdam · Barcelona · Madrid · Milan · Turin · Gothenburg · Vienna · Istanbul · Antwerp · Vilnius · Tirana · Yerevan · Tbilisi · Limassol · Tashkent Middle East & Africa: Riyadh · Abu Dhabi · Cairo Asia-Pacific: Tokyo · Osaka · Kyoto · Singapore · Seoul · Shanghai · Beijing · Shenzhen · Jakarta · Kuala Lumpur · Phnom Penh · GIFT City